CytomX Therapeutics, Inc. (CTMX)
3.29
+0.01
(+0.30%)
USD |
NASDAQ |
Aug 24, 16:00
3.295
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Debt to Equity Ratio : 0.0189 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0189 |
| March 31, 2026 | 0.0089 |
| December 31, 2025 | 0.0428 |
| September 30, 2025 | 0.0521 |
| June 30, 2025 | 0.0574 |
| March 31, 2025 | 0.3253 |
| December 31, 2024 | -20.58 |
| September 30, 2024 | -0.4519 |
| June 30, 2024 | -0.3761 |
| March 31, 2024 | -0.4063 |
| December 31, 2023 | -0.2945 |
| September 30, 2023 | -0.2938 |
| June 30, 2023 | -0.1891 |
| March 31, 2023 | -0.1971 |
| December 31, 2022 | -0.2106 |
| September 30, 2022 | 0.6678 |
| June 30, 2022 | 0.409 |
| March 31, 2022 | 0.3051 |
| December 31, 2021 | -47.22 |
| September 30, 2021 | 0.2017 |
| June 30, 2021 | 0.1781 |
| March 31, 2021 | 0.1651 |
| December 31, 2020 | 0.4994 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.5331 |
| June 30, 2020 | 0.4474 |
| March 31, 2020 | 0.3871 |
| December 31, 2019 | 0.5416 |
| September 30, 2019 | 0.3452 |
| June 30, 2019 | 0.2852 |
| March 31, 2019 | 0.2411 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0148 |
| June 30, 2015 | 0.0361 |
| March 31, 2015 | -0.4408 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
| Ocugen, Inc. | -5.314 |
| iBio, Inc. | 0.03 |
| Cardiff Oncology, Inc. | 0.0172 |
| Capricor Therapeutics, Inc. | 0.3698 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 381.23M |
| Total Liabilities (Quarterly) | 79.16M |
| Shareholders Equity (Quarterly) | 302.07M |
| Current Ratio | 9.361 |
| Net Debt Paydown Yield | 0.06% |